Floatz logo

LENALIDOMIDE

Myelodysplastic Syndrome

Medical College of WisconsinSmall moleculePhase 2Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
73/ 100

Competitive context

295 Active assets in the Myelodysplastic Syndrome cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
Busulphan
Sawa Ito, MD
Phase 4BB
Daunorubicin
OHSU Knight Cancer Institute
Phase 3BB
CYTARABINE
The First Affiliated Hospital of Soochow University
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

LENALIDOMIDE is also rated in:

adult T-cell leukemia/lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
plasma cell neoplasmDormant
BBB
Indicative ·
72 / 100
View asset →
B-cell non-Hodgkin lymphomaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →